Mr. Mielke is a fundamental research analyst at Causeway. He joined the firm in September 2023. His current responsibilities include coverage of companies in the technology and communication services sectors.
Prior to joining Causeway, Mr. Mielke was a senior equity research associate at Jefferies, covering communications infrastructure. From 2020 to 2021, he was an equity research associate at Stifel, covering application and security software.
Mr. Bullock is a senior natural language processing/artificial intelligence analyst at Causeway. He joined the firm in December 2022.
Prior to joining Causeway, Mr. Bullock worked at several startups that focused on leveraging NLP in personal finance, health, and customer service. Highlights of his career include building the Bloomberg Social Velocity terminal function at Bloomberg, publishing a Portuguese-language book on AI, writing a programming language, and demoing his software to Canadian Prime Minister Trudeau in the Creative Destruction Labs event in Toronto, Canada.
Nicholas Wells, CFA
Mr. Wells is a fundamental senior research analyst at Causeway. He joined the firm in May 2023. His current responsibilities include coverage of companies in the consumer discretionary and consumer staples sectors.
Prior to joining Causeway, Mr. Wells was a partner at Poplar Forest Capital, covering the consumer discretionary, consumer staples, and materials sectors. From 2013 to 2017, he was a research associate at Capital Group Companies. Prior to that, Mr. Wells was a research associate at UBS Investment Bank.
Mr. Dong is a quantitative research analyst at Causeway. He joined the firm in March 2023. His current responsibilities include alpha research and alternative data analysis.
From 2020 to 2023, Mr. Dong was at data scientist at Point72 Asset Management, covering US industrials sector. Prior to that, he was a senior strategy/analytics consultant at Deloitte LLP.
Kathryn Hall is a business development associate. She joined the firm in April 2022.
From 2021 to 2022, Ms. Hall worked in sales and marketing at Wisetail, an Intertek Company.
Danielle Durkovic is a reporting analyst. She joined the firm in November 2022.
Ryan Greenwald, CPA
Mr. Greenwald is a fundamental research analyst at Causeway. He joined the firm in November 2022 with current coverage responsibilities including global utilities & clean energy.
Prior to joining Causeway, Mr. Greenwald spent over five years as a sell side equity analyst supporting #1 Institutional Investor ranked teams at Bank of America and Wolfe Research, covering US utilities & clean energy along with airfreight & surface transportation.
Ms. Byrne-Slepicka is a fundamental research analyst at Causeway. She joined the firm in November 2022. Her current responsibilities include coverage of companies in the financials and materials sectors.
Prior to joining Causeway, Ms. Byrne-Slepicka was a senior investment risk analyst at Global Atlantic Financial Group. Prior to 2021, Ms. Byrne-Slepicka was an investment portfolio analyst at Global Atlantic.
Mr. Gianatasio is a fundamental research analyst at Causeway. He joined the firm in October 2022. His current responsibilities include coverage of companies in the industrials, materials, and energy sectors.
Prior to joining Causeway, Mr. Gianatasio was an investment banking analyst at Barclays in their global industrials group.
Mr. Scott is a fundamental senior research analyst at Causeway. He joined the firm in August 2022. His current responsibilities include coverage of companies in the pharmaceuticals and biotechnology sectors.
Prior to joining Causeway, Mr. Scott was vice president of Equity Research Large Cap Biotech at J.P. Morgan. From 2017 to 2019, he was an associate at Goldman Sachs covering large cap biopharma. Prior to that, Mr. Scott was an associate at Jefferies LLC, covering Global Large Cap Pharma.
Terms and Conditions of Use:
Please read the following before proceeding, as it explains certain restrictions imposed by law on the distribution of this information and the countries in which Causeway Funds plc is authorised for sale.
Causeway Funds plc (the "Fund") is authorised by the Central Bank of Ireland as an Undertaking for Collective Investment in Transferable Securities pursuant to the European Communities (Undertaking for Collective Investment in Transferable Securities) Regulations 2011 (S.I. 352 of 2011) of Ireland, as amended.
The Fund and its sub-funds are only authorised in certain jurisdictions.
This website is not aimed at any US person (as defined by Regulations S of the US Securities Act of 1933) and is not for distribution and does not constitute an offer to or solicitation to buy any securities in the United States. Purchase orders from US investors or other ineligible investors will not be accepted. This site is not intended for US persons. If you are trying to find information about the Causeway Funds registered for sale in the United States, please go to our Funds page . Restrictions may also apply to residents of other countries.
Subscriptions will only be received and shares issued on the basis of the current prospectus for the Fund and relevant supplement for a sub-fund. It is your responsibility to use such prospectus and supplement, and by making an application you will be deemed to represent that you have read such prospectus and supplement and agree to be bound by its contents. Copies of the prospectus, supplements and, when available, other reports can be obtained from this website. The Fund prices contained in this website are indicative only and should not be relied upon for dealing. No warranty or representation is made with respect to the information contained in this website, including, without limitation, that the information is accurate, complete or timely. None of the information, whether in part or full, should be copied, reproduced or redistributed in any form. Past performance is not indicative of future results.
The information on this website is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security that may be referenced on or through this website. Unless otherwise specified, it is not intended to be directed to any person(s) in particular. Information from this website must not be used in any jurisdiction where prohibited by law and must not be used in a way that would be contrary to local law or legislation. You should not access this site or information on this site if you know that your access would contravene applicable local, national or international laws. No investment advice, tax advice, or legal advice is provided through this website, and you agree that this website will not be used by you for these purposes. No representation is given that shares, products, or services identified on, or accessible through, this website are suitable for any particular investor.
By clicking the box below, you confirm and represent that you are from an eligible jurisdiction to review material relating to the Fund, or that you are authorised to conduct investment business in the jurisdiction within which you are resident and, under the law of that jurisdiction, you are authorised to view material relating to collective investment schemes). It is critical that the information you provide is accurate and a failure to provide accurate information will be a material breach of these terms and conditions.
If you are a resident of any other country please view our strategies.